The newsreader, 60, has presented the weekday news bulletin on BBC One for the past decade, but sparked a flood of concern during the latest live broadcast.
Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED), today announced that Raymond Douglas, ...